Skip to main content
logo
Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
55.80
-0.92 (-1.62%)
Aug 14, 2025, 2:33 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Peptide Therapeutics
434.43M
Log In
Log In
Log In
Log In
Upgrade
Peptide Therapeutics Growth
624.05%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
434.43M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
624.05%
Log In
Log In
Log In
Log In
Upgrade